State Street’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $329M | Sell |
3,116,749
-82,980
| -3% | -$7.35M | 0.01% | 713 |
|
|
2025
Q4 | $279M | Buy |
3,199,729
+33,934
| +1% | +$2.78M | 0.01% | 775 |
|
|
2025
Q3 | $210M | Sell |
3,165,795
-41,748
| -1% | -$2.37M | 0.01% | 913 |
|
|
2025
Q2 | $177M | Buy |
3,207,543
+500,924
| +19% | +$24M | 0.01% | 988 |
|
|
2025
Q1 | $131M | Sell |
2,706,619
-624,442
| -19% | -$26.2M | 0.01% | 1128 |
|
|
2024
Q4 | $129M | Buy |
3,331,061
+147,519
| +5% | +$6.43M | 0.01% | 1189 |
|
|
2024
Q3 | $143M | Buy |
3,183,542
+1,101,218
| +53% | +$44.5M | 0.01% | 1113 |
|
|
2024
Q2 | $72.2M | Sell |
2,082,324
-1,190,161
| -36% | -$34.9M | ﹤0.01% | 1459 |
|
|
2024
Q1 | $94.7M | Buy |
3,272,485
+542,556
| +20% | +$14.8M | ﹤0.01% | 1347 |
|
|
2023
Q4 | $62.6M | Sell |
2,729,929
-1,212,209
| -31% | -$21.2M | ﹤0.01% | 1579 |
|
|
2023
Q3 | $65.8M | Buy |
3,942,138
+390,152
| +11% | +$7.57M | ﹤0.01% | 1449 |
|
|
2023
Q2 | $98.1M | Buy |
3,551,986
+1,138,285
| +47% | +$28.5M | 0.01% | 1234 |
|
|
2023
Q1 | $55.5M | Sell |
2,413,701
-1,379,225
| -36% | -$23.2M | ﹤0.01% | 1586 |
|
|
2022
Q4 | $41.4M | Sell |
3,792,926
-883,756
| -19% | -$7.46M | ﹤0.01% | 1766 |
|
|
2022
Q3 | $39.4M | Sell |
4,676,682
-2,099,587
| -31% | -$19.9M | ﹤0.01% | 1770 |
|
|
2022
Q2 | $53.6M | Buy |
6,776,269
+3,519,461
| +108% | +$42.6M | ﹤0.01% | 1594 |
|
|
2022
Q1 | $77.1M | Buy |
3,256,808
+685,238
| +27% | +$19.3M | ﹤0.01% | 1479 |
|
|
2021
Q4 | $87.9M | Buy |
2,571,570
+557,591
| +28% | +$17.6M | ﹤0.01% | 1396 |
|
|
2021
Q3 | $35.7M | Buy |
2,013,979
+559,359
| +38% | +$23.8M | ﹤0.01% | 2048 |
|
|
2021
Q2 | $65.3M | Sell |
1,454,620
-258,063
| -15% | -$8.52M | ﹤0.01% | 1650 |
|
|
2021
Q1 | $44.4M | Buy |
1,712,683
+228,367
| +15% | +$5.78M | ﹤0.01% | 1824 |
|
|
2020
Q4 | $29.9M | Buy |
1,484,316
+329,763
| +29% | +$7.1M | ﹤0.01% | 1982 |
|
|
2020
Q3 | $22.6M | Buy |
1,154,553
+771,659
| +202% | +$14.5M | ﹤0.01% | 1968 |
|
|
2020
Q2 | $6.76M | Buy |
382,894
+65,102
| +20% | +$817K | ﹤0.01% | 2620 |
|
|
2020
Q1 | $2.24M | Sell |
317,792
-20,378
| -6% | -$153K | ﹤0.01% | 3011 |
|
|
2019
Q4 | $2.38M | Buy |
338,170
+23,127
| +7% | +$230K | ﹤0.01% | 3191 |
|
|
2019
Q3 | $3.78M | Buy |
315,043
+52,333
| +20% | +$660K | ﹤0.01% | 2929 |
|
|
2019
Q2 | $3.18M | Buy |
262,710
+248,658
| +1,770% | +$2.75M | ﹤0.01% | 3050 |
|
|
2019
Q1 | $177K | Sell |
14,052
-246
| -2% | -$2.17K | ﹤0.01% | 3588 |
|
|
2018
Q4 | $96K | Sell |
14,298
-342
| -2% | -$2.71K | ﹤0.01% | 3637 |
|
|
2018
Q3 | $151K | Buy |
14,640
+262
| +2% | +$2.25K | ﹤0.01% | 3620 |
|
|
2018
Q2 | $96K | Sell |
14,378
-138,604
| -91% | -$1.06M | ﹤0.01% | 3634 |
|
|
2018
Q1 | $1.31M | Buy |
152,982
+16,138
| +12% | +$304K | ﹤0.01% | 3293 |
|
|
2017
Q4 | $2.85M | Buy |
136,844
+19,661
| +17% | +$349K | ﹤0.01% | 3050 |
|
|
2017
Q3 | $2.07M | Buy |
117,183
+4,709
| +4% | +$65.2K | ﹤0.01% | 3191 |
|
|
2017
Q2 | $1.27M | Buy |
112,474
+19,411
| +21% | +$208K | ﹤0.01% | 3288 |
|
|
2017
Q1 | $1.19M | Buy |
93,063
+900
| +1% | +$14.5K | ﹤0.01% | 3227 |
|
|
2016
Q4 | $2.03M | Buy |
92,163
+31,042
| +51% | +$692K | ﹤0.01% | 3097 |
|
|
2016
Q3 | $1.29M | Buy |
+61,121
| New | +$835K | ﹤0.01% | 3124 |
|
Other funds holding PTGX
FCM
RI
VPM
VCM
JJ
